International Device Vigilance Program Pilot Could Be Launched By This Fall
This article was originally published in The Gray Sheet
Executive SummaryRegulatory authorities in the U.S., Canada, Japan, Australia and several European countries could begin exchanging reports of medical device adverse events this fall under a proposed pilot international vigilance system.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.